Bryn Mawr Capital Management Inc’s PharMerica Corporation PMC Stock Holding History

Bryn Mawr Capital Management Inc’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-9,557	Closed	-$272K	–	386
2015 Q3	$272K	Buy	+9,557	New	+$321K	0.05%	382
2015 Q1	–	Sell	-25,069	Closed	-$519K	–	642
2014 Q4	$519K	Buy	25,069 +2,711	+12%	+$64.4K	0.07%	240
2014 Q3	$546K	Buy	+22,358	New	+$593K	0.06%	365
2013 Q4	–	Sell	-34,879	Closed	-$463K	–	701
2013 Q3	$463K	Buy	34,879 +11,585	+50%	+$156K	0.03%	338
2013 Q2	$323K	Buy	+23,294	New	+$330K	0.02%	330

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Bryn Mawr Capital Management Inc's PMC Position: Q4 2015 in Review

Bryn Mawr Capital Management Inc sold out of PharMerica Corporation (PMC) in Q4 2015, closing a stake of 9,557 shares — an estimated $272K sold.

Bryn Mawr Capital Management Inc first reported a position in PMC in Q2 2013 and held it in 5 quarters. The position peaked at $546K in Q3 2014. 195 funds tracked by Wall St. Rank hold PMC as of Q4 2015.

Bryn Mawr Capital Management Inc reported no remaining PharMerica Corporation position as of Q4 2015 after selling out during the quarter.
Bryn Mawr Capital Management Inc sold 9,557 PharMerica Corporation shares in Q4 2015, an estimated $272K.
Bryn Mawr Capital Management Inc first reported a position in PharMerica Corporation in Q2 2013 and held it in 5 quarters.
Bryn Mawr Capital Management Inc's PharMerica Corporation position peaked at $546K in Q3 2014.
195 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2015.

Based on Bryn Mawr Capital Management Inc's 13F filing for Q4 2015.